Pradžia › Reumatoidinis artritas › Masčusetsas
Reumatoidinis artritas klinikiniai tyrimai Masčusetsas
8 tyrimai dėl Reumatoidinis artritas ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
RA-PRO PRAGMATIC TRIAL
- Tufts University, Boston
- University of Massachusetts Chan Medical School, Worcester
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Massachusetts General Hospital, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-21 · NCT06570798A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Brigham And Womens Hospital, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-14 · NCT07115745The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
- Massachusetts General Hospital: Rheumatology, Boston
- Brigham and Womens Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 35 iki 79 · Visoms lytims · Atnaujinta 2026-07-14 · NCT07315997Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Renkami dalyviai1 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-06-30 · NCT06201416A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Research Site, New Bedford
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-24 · NCT07276581A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 71 · Visoms lytims · Atnaujinta 2026-04-16 · NCT07123038Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.